InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,780.05
(
-0.21%
)
US TECH 100
19,706.78
(
-0.10%
)
Dow Jones
42,454.12
(
-0.14%
)
Brent Oil
79.06
(
3.17%
)
Bitcoin
60,088.15
(
-0.81%
)
Post# of 17564
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Jesspro

Send PM Follow Ignore
Followers 40
Posts 6078
Boards Moderated 1
Alias Born 06/29/2011

Jesspro

Re: moosedogger post# 15503

Friday, 07/08/2022 9:41:45 PM

Friday, July 08, 2022 9:41:45 PM

Post# of 17564
Moose, If Auph dosing protocol patent applies only for Lupus Nephritis, then they may have a sliver of a case for the other indication(Eye treatment ) as the litigation involves only patent infringement for the eye condition. I think Voclosporin trial data for this indication is not strong enough that’s why they shelved it. I don’t know if Auph applied for a patent on the dosing protocol like the one they did for LN.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AUPH News
More AUPH News
InvestorsHub NewsWire

FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM

FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM

Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM

Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM

Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM

BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!